Zewei Wang

12PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer cell biologyMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 29, 2026
Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma.

|May 20, 2026
Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma.

|May 15, 2026
Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpression.

|Dec 10, 2025
Natural killer cell infiltration elicits gender-dependent dichotomous clinical outcomes in urothelial carcinoma.

Lingkai Zhang, Zhaopei Liu, Yawei Ding

|Aug 11, 2025
ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma.

Zhaopei Liu, Lingkai Zhang, Kaifeng Jin

|Jan 06, 2025
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression.

Kaifeng Jin, Yawei Ding, Jingtong Xu

Pageof 2

Frequent Collaborators

11 joint publications

Kaifeng Jin

10 joint publications

Jiejie Xu

10 joint publications

Zhaopei Liu

9 joint publications

Han Zeng